Search clinical trials for: LDL reduction

Total 4926 results

Samsung Medical Center

Recruiting

Optimal Attained LDL-Cholesterol Levels in Patients Who Achieved ≥50% LDL Reduction After PCI (Lipid-PCI)

Coronary Artery Disease | Hyperlipidemias

Korea, Republic of
John Sievenpiper

Not yet recruiting

Meta-analyses of Soy Protein and Its Food Sources for Cholesterol Reduction

Dyslipidemias | Cardiovascular Risk Factor | Dysglycemia

Canada
Perrigo CSCI
Analyze & Realize

Recruiting

Effects of Arterin Cholesterol for Reduction of Lipid Levels

Blood Cholesterol Lowers | LDL-C

Germany
LIB Therapeutics LLC
Medpace, Inc.

Active, not recruiting

Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction (LIBerate-HR)

Cardiovascular Diseases | Hypercholesterolemia | Cardiovascular Risk Factor | Cardiovascular Stroke

United States, Israel, India
LIB Therapeutics LLC
Medpace, Inc.

Active, not recruiting

Study of Efficacy and Safety of LIB003 in Patient With CVD on Statins Requiring Additional LDL-C Reduction (LIBerate-CVD)

Cardiovascular Diseases | Hyper-LDL-cholesterolemia

United States
LIB Therapeutics LLC
Medpace, Inc.

Completed

Study to Assess the Efficacy and Safety of LIB003 in HeFH Patients on Oral Lipid Therapy Needing Further LDL-C Reduction (LIBerate-FH)

Heterozygous Familial Hypercholesterolemia

United States, Israel, Norway, South Africa, Turkey
Baylor College of Medicine
Merck Sharp & Dohme LLC

Completed

Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 a Subfraction of LDL in Patients With Metabolic Syndrome. (Merck-123)

Metabolic Syndrome

United States
LIB Therapeutics LLC
Medpace, Inc.

Enrolling by invitation

Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction (LIBerate-OLE)

Familial Hypercholesterolemia | Elevated Cholesterol | Cardiovascular Disease With Mention of Arteriosclerosis

United States, Israel, Norway, South Africa, Turkey, India
OncoImmune, Inc.
University of Maryland, Baltimore

Terminated

Efprezimod Alfa (CD24Fc, MK-7110) Administration to Decrease Low-Density Lipoprotein (LDL) and Inflammation in Human Immunodeficiency Virus (HIV) Patients (CALIBER) (MK-7110-003) (CALIBER)

HIV Infections | Dyslipidemias

United States
Amgen

Completed

Reduction of Low-Density Lipoprotein Cholesterol (LDL-C) With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study (RUTHERFORD)

Hypercholesterolemia, Familial
Policlinico Casilino ASL RMB
IRCCS San Raffaele

Unknown

Evolocumab Plus Ezetimibe in Haemodialized Statin-intolerant Patients With Hypercholesterolemia

Hypercholesterolemia | CKD Stage 5 | Chronic Kidney Disease Requiring Chronic Dialysis

Italy
Charite University, Berlin, Germany

Completed

Safety and Efficacy of Propionate for Reduction of LDL Cholesterol (PROPER-LDL)

Hypercholesterolemia

Germany
University of Pennsylvania
National Institute on Aging (NIA); Rutgers University; Carnegie Mellon University

Completed

Habit Formation for Adherence to Statin Use and LDL Reduction

Medication Adherence

United States
University of Nottingham
Biotechnology and Biological Sciences Research Council

Completed

Impact of Reducing Dietary Intake of Red and Processed Meat Intake on Fasting Lipemia in Healthy Participants (ELM)

Lipidemia

United Kingdom
University Hospital Inselspital, Berne
Amgen; University of Bern

Completed

EVOlocumab for Early Reduction of LDL-cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS) (EVOPACS)

Acute Coronary Syndrome

Switzerland
Amgen

Completed

Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2 (RUTHERFORD-2)

Hyperlipidemia

Canada, France, Netherlands, United Kingdom, New Zealand, South Africa, Spain, United States, Australia, Germany, Sweden, Hong Kong, Switzerland, Norway
LIB Therapeutics LLC
Medpace, Inc.

Completed

Study to Evaluate Efficacy and Safety of LIB003 in Patients on Lipid-Lowering Therapy Needing Additional LDL-C Reduction

LDL Cholesterol

United States
B. Braun Medical Inc.

Completed

(H.E.L.P.)Apheresis Therapy to Compare the Reduction of LDL (Low Density Lipoprotein) Cholesterol (FUTURA)

Hypercholesterolemia

United States
AB Biotics, SA

Completed

A Trial to Evaluate the Efficacy of AB-Life Probiotic Product on LDL-Cholesterol Reduction in Moderate Hypercholesterolemia

Moderate Hypercholesterolemia

France
Amgen

Completed

Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk (AMG145)

Hyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascular Events

Japan
Nordic Pharma, USA
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Withdrawn

Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction (PrOteCT)

Mixed Hyperlipoproteinemia
Unity Health Toronto
Canadian Diabetes Association

Completed

Innovative Strategies For Risk Reduction Following CABG

Coronary Artery Disease | Type II Diabetes Mellitus

Canada
Pfizer

Completed

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels (TNT)

Cardiovascular Disease | Coronary Heart Disease | Cerebrovascular Accident

United States, Australia, Netherlands, Canada, Spain, France, Austria, Italy, South Africa, Belgium, Germany, Switzerland, Ireland, United Kingdom
University of Barcelona
University Ramon Llull; ICREA Academia; Institut de Neurociències de la Universitat... and other collaborators

Recruiting

Active Young, Healthy Mind. The YoungFitT Project (YoungFitT)

University Students

Spain
University of Bologna

Not yet recruiting

Effect of a Dietary Supplement on Lipid Pattern, Indexes of NAFLD and Systemic Inflammation in Healthy Subjects With Suboptimal LDL-C Levels

Inflammation | Hypercholesterolemia

Italy
Pivot Health Technologies Inc.

Not yet recruiting

Study of a Smartphone-Based Alcohol Reduction Program

Alcohol Use, Unspecified

United States
Beni-Suef University

Not yet recruiting

Effect of Intra-articular Injection of Tenoxicam or Meloxicam in TMJ Anterior Disc Displacement With Reduction

Temporomandibular Joint Disc Displacement, With Reduction
University of California, San Francisco
National Institute on Aging (NIA)

Recruiting

Enhancing Attention and Wellbeing Using Digital Therapeutics

Aging | Cognitive Decline | MCI

United States
Brazilian Clinical Research Institute
Alliança Diagnostic

Not yet recruiting

Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke (ARCHIMEDES)

Ischemic Stroke
University of Maryland, Baltimore

Not yet recruiting

Assessment of Fall Risks and Subject-specific Training for Fall Reduction

Fall Risk
Médecins du Monde
University of Bristol; PATH; UNITAID; Burnet Institute; Population Services International and other collaborators

Not yet recruiting

Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries

Hepatitis | Hiv | Drug Use
Pauls Stradins Clinical University Hospital

Recruiting

Latvian Early Atherosclerosis Registry

Coronary Artery Disease | Atherosclerosis, Coronary

Latvia
Cairo University

Recruiting

CAD/CAM Angle Fracture Reduction/Plate Guide and Customized 3D Grid Plate Versus Champy's Technique

Mandibular Fractures

Egypt
National Taipei University of Nursing and Health...

Not yet recruiting

MBI in Generation Z Nursing Students During Clinical Practicum (MBI)

Depression | Anxiety | Mental Health | Resilience
Radboud University Medical Center

Recruiting

Mindfulness-Based Stress Reduction (MBSR) for People High on the Personality Trait Sensory Processing Sensitivity: A Mixed Methods Study (MindSens)

Sensory Processing Sensitivity

Netherlands
Eli Lilly and Company

Not yet recruiting

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Renal Function in Adults Living With Obesity (TRIUMPH-OUTCOMES)

Overweight and Obesity

United States, Canada, Australia, Germany, Mexico, Argentina, Brazil, Hungary, Austria, India, Poland, Slovakia, Spain, Netherlands, Turkey, Czechia, United Kingdom, Denmark, Puerto Rico, France, Israel
University Health Network, Toronto

Not yet recruiting

Topical TRanexamic Acid vs. Placebo on Acute Postoperative Pain Following DRF Fixation (TRADR)

Distal Radius Fractures

Canada
University of Catania

Recruiting

Impact of Non-surgical Periodontal Treatment of miRNome

Periodontitis

Italy
Nordsjaellands Hospital

Recruiting

Ultrasound-guided Infraclavicular Block With Lidocaine or Ropivacaine for Closed Reduction of Distal Radius Fractures

Colles' Fracture | Fracture Dislocation | Distal Radius Fractures | Lidocaine | Ropivacaine | Closed Reduction of Fracture and Application of Plaster Cast

Denmark
Vastra Gotaland Region

Recruiting

Lifestyle Intervention With Physical Activity and Diet (LI-PAD)

Overweight

Sweden
University of Aarhus

Not yet recruiting

Tonsillectomy vs. Tonsillotomy in Adults With Obstructive Sleep Apnea

Obstructive Sleep Apnea | Tonsillar Hypertrophy
University of Pennsylvania
National Cancer Institute (NCI)

Not yet recruiting

Alternative Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers

Tobacco Use | Harm Reduction | Cigarette Smoking | E-cigarette Use
Centre Hospitalier Universitaire de Nīmes

Not yet recruiting

Continuous Veno-venous Hemodialysis and Continuous Veno-venous Hemodiafiltration on Urea Reduction Rate in Intensive Care Patient (CompEER)

Acute Kidney Injury | Continuous Renal Replacement Therapy | Intensive Care Unit

France
University of Aarhus

Recruiting

Pharmacokinetics of Dexamethasone in Childhood ALL and Reduction in Bone Mineral Density

Acute Lymphoblastic Leukemia

Denmark
Jessica Merlin
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Pain Self-Management and Patient-Oriented Dosing for Pain and in Retention Opioid Treatment (TREETOP)

Chronic Pain | Opioid Use Disorder

United States
University of Bergen
The Norwegian Seafood Research Fund

Not yet recruiting

Effect of Herring Oil Concentrate on LDL Cholesterol Concentration in Adults

High Cholesterol

Norway
Beijing Luhe Hospital

Recruiting

Effects of PCSK-9 Inhibitor Treatment Prior to Undergoing Primary Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction

STEMI

China
Centre Hospitalier St Anne

Not yet recruiting

Reduction of Auditory-Verbal Hallucinations in Schizophrenia Through Cortical Neuromodulation (HALLUSTIM)

Treatment Resistant Schizophrenia
Singapore ETH Centre
Nanyang Technological University; ETH Zurich; National University of Singapore

Recruiting

The LvL UP Pilot Trial

Health Behavior | Noncommunicable Diseases | Mental Health Issue | Lifestyle Risk Reduction

Singapore
Boston Children's Hospital

Not yet recruiting

GF-NOURISH (Gluten Free Nutrition Optimization Through Ultra-processed Food Reduction and Improved Strategies for Health) (GF-NOURISH)

Celiac Disease in Children | Nutrition Disorder, Child

United States

Search clinical trials for: LDL reduction

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations